186 related articles for article (PubMed ID: 35400813)
1. Induction of mucosal healing by intensive granulocyte/monocyte adsorptive apheresis (GMA) without use of corticosteroids in patients with ulcerative colitis: long-term remission maintenance after induction by GMA and efficacy of GMA re-treatment upon relapse.
Fukuchi T; Kawashima K; Koga H; Utsunomiya R; Sugiyama K; Shimazu K; Eguchi T; Ishihara S
J Clin Biochem Nutr; 2022 Mar; 70(2):197-204. PubMed ID: 35400813
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
[TBL] [Abstract][Full Text] [Related]
3. Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.
Tanida S; Mizoshita T; Nishie H; Ozeki K; Katano T; Kubota E; Kataoka H; Kamiya T; Joh T
J Clin Med Res; 2015 Nov; 7(11):884-9. PubMed ID: 26491502
[TBL] [Abstract][Full Text] [Related]
4. Adsorptive granulocyte/monocyte apheresis for the maintenance of remission in patients with ulcerative colitis: a prospective randomized, double blind, sham-controlled clinical trial.
Fukunaga K; Yokoyama Y; Kamokozuru K; Nagase K; Nakamura S; Miwa H; Matsumoto T
Gut Liver; 2012 Oct; 6(4):427-33. PubMed ID: 23170145
[TBL] [Abstract][Full Text] [Related]
5. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis.
Tanida S; Ozeki K; Mizoshita T; Kitagawa M; Ozeki T; Tanaka M; Nishie H; Shimura T; Kubota E; Kataoka H
J Clin Med Res; 2020 Jan; 12(1):36-40. PubMed ID: 32010420
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
Ishiguro Y; Ohmori T; Umemura K; Iizuka M
Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
[TBL] [Abstract][Full Text] [Related]
8. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
[TBL] [Abstract][Full Text] [Related]
9. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study.
Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M
J Clin Apher; 2023 Aug; 38(4):406-421. PubMed ID: 36636880
[TBL] [Abstract][Full Text] [Related]
10. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.
Iida T; Ikeya K; Kato M; Abe J; Yamamoto M; Watanabe F; Sugimoto K; Hanai H
Digestion; 2017; 96(2):119-126. PubMed ID: 28796990
[TBL] [Abstract][Full Text] [Related]
11. Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports.
Furuto Y; Sawada R; Namikawa A; Matsuhashi N; Shibuya Y
Cureus; 2023 Aug; 15(8):e43599. PubMed ID: 37719478
[TBL] [Abstract][Full Text] [Related]
12. Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor.
Tanida S; Ozeki K; Katano T; Tanaka M; Shimura T; Kubota E; Kataoka H; Takahama T; Sasoh S; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
J Clin Med Res; 2023 Mar; 15(3):181-186. PubMed ID: 37035853
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis.
Tsuzuki Y; Shiomi R; Matsumoto H; Miyaguchi K; Kusano T; Ohgo H; Nakamoto H; Imaeda H
J Clin Biochem Nutr; 2023 Jan; 72(1):68-73. PubMed ID: 36777077
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
[TBL] [Abstract][Full Text] [Related]
15. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction for Intractable Ulcerative Colitis.
Tanida S; Sasoh S; Otani T; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
J Clin Med Res; 2024 May; 16(5):256-263. PubMed ID: 38855784
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.
Tanida S; Ozeki K; Kanno T; Katano T; Sugimura N; Nishie H; Iwasaki H; Tanaka M; Shimura T; Kubota E; Kataoka H
J Clin Med Res; 2021 Nov; 13(10-11):510-514. PubMed ID: 34925662
[TBL] [Abstract][Full Text] [Related]
18. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
Yokoyama Y; Kawai M; Fukunaga K; Kamikozuru K; Nagase K; Nogami K; Kono T; Ohda Y; Iimuro M; Hida N; Nakamura S; Miwa H; Matsumoto T
BMC Gastroenterol; 2013 Feb; 13():27. PubMed ID: 23399416
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Yamamoto T; Umegae S; Matsumoto K
J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
[TBL] [Abstract][Full Text] [Related]
20. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.
Sagawa T; Kakizaki S; Tomizawa T; Nakayama T; Tanaka H; Tojima H; Sato K; Kusano M; Okamura S; Yamada M
Colorectal Dis; 2016 Jul; 18(7):696-702. PubMed ID: 26748553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
